Tetrandrine Tablets Used in the Treatment of COVID-19
Status:
Enrolling by invitation
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
The study is expected to treat patients with mild and severe neo-coronary pneumonia through
standard treatment regimens in combination with tetrandrine tablets, thereby reducing the
clinical progress of some patients, improving prognosis, reducing the incidence of pulmonary
fibrosis during rehabilitation, and improving patients' quality of life.